Health Condition 1: L638- Other alopecia areata
Conditions
Interventions
Intervention1: Microneedling with topical minoxidil 5% gel: 5% minoxidil gel (amount depending on area to be covered) will be applied on the selected patches of alopecia areata followed by microneedli
Sponsors
Dr. Harmandeep Kaur
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged 18-50 years of age with limited patches of alopecia areata (upto 5 patches). 2.Patients who are willing to sign the written consent form prior to participation in the study.
Exclusion criteria
Exclusion criteria: 1.Patient having history of hypersensitivity to minoxidil or tofacitinib. 2.Active scalp infection. 3.Subjects with history of bleeding, platelet disorders. 4.History of uncontrolled diabetes mellitus and hypertension. 5.Pregnant and lactating females. 6.Immunocompromised patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Reduction in SALT score 2. Dermoscopic and photographic improvementTimepoint: At the starting of the treatment, at every visit and 4 weekly for next 16 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of microneedling with topical minoxidil 5 percent gel versus microneedling with topical 2 percent tofacitinib gel using adverse drug reaction formTimepoint: At every visit & 4 weekly for next 16 weeks. | — |
Countries
India
Contacts
Public ContactDr Harmandeep Kaur
Guru Gobind Singh medical college and Hospital, Faridkot
Outcome results
None listed